Dapeng Liu1,2, Dan Zhu3, Wenbo Li1,2, and Qin Qin1,2
1Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, 3Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
Prostate perfusion mapping using velocity-selective arterial
spin labeling (VSASL) is desired for higher
SNR and insensitivity to arterial transit delay. The choice of
cutoff velocity (Vc) determines its sensitivity to perfusion-weighted signal
(PWS). The utility of Fourier-transform based velocity-selective (FT-VS) pulse
trains have been demonstrated in cerebral blood flow and cerebral blood volume mapping.
In this study, FT-VS prepared blood flow and blood volume mapping sequences
were performed in parallel in both brain and prostate to investigate their Vc dependence
to PWS. The results suggest that lower Vc is demanded for prostate VSASL.
Introduction
Prostate blood flow (PBF) was only estimated by pulsed ASL
methods1,2, which suffer from
low SNR and high sensitivity to arterial transit delay. Velocity-selective arterial
spin labeling (VSASL) can potentially overcome these limitations and is thus an
attractive technique to explore. The sensitivity of VSASL techniques to
perfusion signal is critically dependent on the choice of cutoff velocity (Vc)3,4 and might be
different in various organs. For conventional velocity-selective saturation
(VSS) pulse trains, Vc is typically around 2cm/s for quantifying cerebral blood
flow (CBF); Rather low Vc of 0.35-0.7cm/s was applied in a study estimating
total cerebral blood volume (CBV)5. Recently, Fourier-transform
based velocity-selective inversion (FT-VSI) and saturation (FT-VSS) pulse trains
have been applied for quantifying CBF with a 2.8cm/s Vc6 and CBV with a 0.7cm/s Vc7. This work investigates
these new 3D perfusion imaging techniques for blood flow and blood volume in both brain
and prostate in parallel, with Vcs ranging from 2.10 to 0.35cm/s. Methods
Experiments among four healthy male volunteers (34±7yrs) were
performed on a 3T Siemens Prisma scanner, ) with a 20-channel head/neck
receiver coil for brain imaging and an 18-channel body coil for prostate
imaging in a single session.
Blood flow and blood volume mapping utilized a 96ms FT-VS
labeling module as shown in Figure 1a, with excitation pulses of 20° (FT-VSI) for
blood flow and 10°
(FT-VSS) for blood volume mapping. Strength of velocity-encoding gradients was
varied to achieve four Vcs: 0.35/0.70/1.40/2.10cm/s. The blood flow mapping
sequence contained a spatially selective saturation module, an FT-VS label/control
module, three background suppression pulses, a flow-dephasing module with
similar Vcs as the labeling module, and an inner-volume-excitation single-shot
3D GRASE readout (Figure 1b). An additional spatially selective saturation was
used for prostate imaging to suppress bladder signal right before the
flow-dephasing module. Post saturation delay (PSD) was 3s; post labeling delay
(PLD) was 1.2s; TR was 4.6s; and total duration was 3.5min, including 20
dynamics. The blood volume mapping sequence was similar except no background-suppression
or flow-dephasing module were used (Figure 1c). PSD was 3.5s; no PLD; TR was 3.9s;
and total duration was 3min with also 20 dynamics.
The reduced field-of-view was 82×82×40mm3 with an
acquisition resolution of 3.4×3.4×4mm3 covering the middle of the
brain and the whole prostate gland. The EPI factor was 13, and the fast-spin-echo
factor was 12. Bandwidth was 2894Hz with an echo spacing of 11.8ms. Echo
duration was therefore 142ms. A proton density-weighted M0 image and a double
inversion recovery (DIR) image that suppressed white matter (WM) and CSF in
brain, and urine in prostate were also acquired with the same readout.
Visual inspection was conducted to remove dynamics with
motion artifacts. Perfusion-weighted signal (PWS) was calculated as averaged subtraction
between label/control pairs divided by M0. Temporal SNR (tSNR) of the subtraction
through the dynamics was also recorded.Results and Discussion
The blood flow and blood volume mappings of both brain and
prostate from one representative subject were shown in Figure 2. One-slice
examples from all four subjects were shown in Figure 3. Mean and standard
deviation of PWS in ROIs of gray matter (GM), WM, and prostate were shown in Figure
4 and Table 1.
For CBF mapping, PWS is consistent for Vc of 0.70/1.40/2.10cm/s,
indicating a relatively stable labeling efficiency. Vc of 0.35cm/s showed a
higher blood flow PWS in both GM and WM, probably caused by diffusion effect
(see Table 1). Surprisingly, tSNR decreased with lower Vc, which may indicate
more CSF signal being unintentionally labeled as CSF has a slow velocity. For CBV
mapping, both GM and WM showed increased PWS with lower Vc, indicating higher
labeling efficiency. However, even with the higher Vc of 1.4/2.1cm/s, the CBV
contrast between GM and WM is still largely preserved.
For PBF and prostate blood volume (PBV) mapping, both PWS
showed a much sharper increase with lowering Vc, indicating an overall slower moving
of blood in prostate than in brain. This leads to substantial signal loss for
high Vcs of 1.4/2.1cm/s. In addition, the prostate PWS also showed a lower tSNR
than brain GM and WM, probably caused by intrinsically more local motion of
prostate.
For both brain and prostate, blood volume PWS showed up to
three times higher tSNR than blood flow. Blood flow mapping also seemed to show
a better contrast between GM and WM than blood volume mapping, probably due to
more accumulated signal in tissue than vessels. It is worth noting that with
such low Vc used in this study, the diffusion effect may be a confounding
factor. Based on normal T1, T2 and ADC of brain and prostate, we simulated the
potentially overestimated PWS from diffusion as shown in Table 1.Conclusion
Vc dependence of FT-VS based PWS was compared for both brain
and prostate at 3T. For prostate, a low Vc of 0.35cm/s seemed necessary for
both blood flow and blood volume mapping to get adequate signal. As in brain,
PBV mapping yielded a higher tSNR than PBF. Both methods need to be evaluated
in more healthy subjects and patients to demonstrate their clinical utilities.Acknowledgements
No acknowledgement found.References
1. Li X, Metzger GJ. Feasibility of measuring prostate perfusion with
arterial spin labeling. NMR Biomed. 2013;26:51–57.
2. Cai W, Li F, Wang J, et al. A comparison of arterial spin labeling
perfusion MRI and DCE-MRI in human prostate cancer. NMR Biomed.
2014;27:817–825.
3. Wong EC, Cronin M, Wu WC, Inglis B, Frank LR, Liu TT.
Velocity-selective arterial spin labeling. Magn. Reson. Med. 2006;55:1334–1341.
4. Wu WC, Wong EC. Intravascular effect in velocity-selective arterial
spin labeling: The choice of inflow time and cutoff velocity. Neuroimage
2006;32:122–128.
5. Liu D, Xu F, Lin DD, van Zijl PCM, Qin Q. Quantitative measurement of
cerebral blood volume using velocity-selective pulse trains. Magn. Reson. Med.
2017;77:92–101.
6. Qin Q, van Zijl PCM. Velocity-selective-inversion prepared arterial
spin labeling. Magn. Reson. Med. 2016;76:1136–1148.
7. Qin Q,
Qu Y, Li W, et al. Cerebral blood volume mapping using Fourier-transform-based
velocity-selective saturation pulse trains. Magn. Reson. Med.
2019;81:3544–3554.